Phage based vaccine: A novel strategy in prevention and treatment
The vaccine was first developed in 1796 by a British physician, Edward Jenner, against the smallpox virus. This invention revolutionized medical science and saved lives around the world. The production of effective vaccines requires dominant immune epitopes to elicit a robust immune response. Thus,...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-09-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023071335 |
| _version_ | 1797669798806552576 |
|---|---|
| author | Sharareh Mohammad Hasani Elham Ghafouri Shirin Kouhpayeh Forouzan Amerizadeh Ilnaz Rahimmanesh Zohre Amirkhani Hossein Khanahmad |
| author_facet | Sharareh Mohammad Hasani Elham Ghafouri Shirin Kouhpayeh Forouzan Amerizadeh Ilnaz Rahimmanesh Zohre Amirkhani Hossein Khanahmad |
| author_sort | Sharareh Mohammad Hasani |
| collection | DOAJ |
| description | The vaccine was first developed in 1796 by a British physician, Edward Jenner, against the smallpox virus. This invention revolutionized medical science and saved lives around the world. The production of effective vaccines requires dominant immune epitopes to elicit a robust immune response. Thus, applying bacteriophages has attracted the attention of many researchers because of their advantages in vaccine design and development. Bacteriophages are not infectious to humans and are unlikely to bind to cellular receptors and activate signaling pathways. Phages could activate both cellular and humoral immunity, which is another goal of an effective vaccine design. Also, phages act as an effective adjuvant, along with the antigens, and induce a robust immune response. Phage-based vaccines can also be administered orally because of their stability in the gastrointestinal tract, in contrast to common vaccination routes, which are intradermal, subcutaneous, or intramuscular. This review presents the current improvements in phage-based vaccines and their applications as preventive or therapeutic vaccines. |
| first_indexed | 2024-03-11T20:50:00Z |
| format | Article |
| id | doaj.art-d474841fe2f64fdc953810c90c6aacba |
| institution | Directory Open Access Journal |
| issn | 2405-8440 |
| language | English |
| last_indexed | 2024-03-11T20:50:00Z |
| publishDate | 2023-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj.art-d474841fe2f64fdc953810c90c6aacba2023-10-01T06:01:52ZengElsevierHeliyon2405-84402023-09-0199e19925Phage based vaccine: A novel strategy in prevention and treatmentSharareh Mohammad Hasani0Elham Ghafouri1Shirin Kouhpayeh2Forouzan Amerizadeh3Ilnaz Rahimmanesh4Zohre Amirkhani5Hossein Khanahmad6Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranErythron Genetics and Pathobiology Laboratory, Department of Immunology, Isfahan, IranDepartment of Neurology, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranApplied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Corresponding author.The vaccine was first developed in 1796 by a British physician, Edward Jenner, against the smallpox virus. This invention revolutionized medical science and saved lives around the world. The production of effective vaccines requires dominant immune epitopes to elicit a robust immune response. Thus, applying bacteriophages has attracted the attention of many researchers because of their advantages in vaccine design and development. Bacteriophages are not infectious to humans and are unlikely to bind to cellular receptors and activate signaling pathways. Phages could activate both cellular and humoral immunity, which is another goal of an effective vaccine design. Also, phages act as an effective adjuvant, along with the antigens, and induce a robust immune response. Phage-based vaccines can also be administered orally because of their stability in the gastrointestinal tract, in contrast to common vaccination routes, which are intradermal, subcutaneous, or intramuscular. This review presents the current improvements in phage-based vaccines and their applications as preventive or therapeutic vaccines.http://www.sciencedirect.com/science/article/pii/S2405844023071335BacteriophageVaccinePhage-based vaccine |
| spellingShingle | Sharareh Mohammad Hasani Elham Ghafouri Shirin Kouhpayeh Forouzan Amerizadeh Ilnaz Rahimmanesh Zohre Amirkhani Hossein Khanahmad Phage based vaccine: A novel strategy in prevention and treatment Heliyon Bacteriophage Vaccine Phage-based vaccine |
| title | Phage based vaccine: A novel strategy in prevention and treatment |
| title_full | Phage based vaccine: A novel strategy in prevention and treatment |
| title_fullStr | Phage based vaccine: A novel strategy in prevention and treatment |
| title_full_unstemmed | Phage based vaccine: A novel strategy in prevention and treatment |
| title_short | Phage based vaccine: A novel strategy in prevention and treatment |
| title_sort | phage based vaccine a novel strategy in prevention and treatment |
| topic | Bacteriophage Vaccine Phage-based vaccine |
| url | http://www.sciencedirect.com/science/article/pii/S2405844023071335 |
| work_keys_str_mv | AT shararehmohammadhasani phagebasedvaccineanovelstrategyinpreventionandtreatment AT elhamghafouri phagebasedvaccineanovelstrategyinpreventionandtreatment AT shirinkouhpayeh phagebasedvaccineanovelstrategyinpreventionandtreatment AT forouzanamerizadeh phagebasedvaccineanovelstrategyinpreventionandtreatment AT ilnazrahimmanesh phagebasedvaccineanovelstrategyinpreventionandtreatment AT zohreamirkhani phagebasedvaccineanovelstrategyinpreventionandtreatment AT hosseinkhanahmad phagebasedvaccineanovelstrategyinpreventionandtreatment |